These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30202522)

  • 1. Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium.
    Van Valckenborgh E; Hébrant A; Antoniou A; Van Hoof W; Van Bussel J; Pauwels P; Salgado R; Van Doren W; Waeytens A; Van den Bulcke M
    Arch Public Health; 2018; 76():49. PubMed ID: 30202522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision cancer medicine: What has translated into clinical use in Belgium?
    Delnord M; Van Valckenborgh E; Hebrant A; Antoniou A; Van Hoof W; Waeytens A; Van den Bulcke M
    Semin Cancer Biol; 2022 Sep; 84():255-262. PubMed ID: 34129914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program.
    Delcourt T; Vanneste K; Soumali MR; Coucke W; Ghislain V; Hebrant A; Van Valckenborgh E; De Keersmaecker SCJ; Roosens NH; Van De Walle P; Van Den Bulcke M; Antoniou A
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33138022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.
    Horgan D; Curigliano G; Rieß O; Hofman P; Büttner R; Conte P; Cufer T; Gallagher WM; Georges N; Kerr K; Penault-Llorca F; Mastris K; Pinto C; Van Meerbeeck J; Munzone E; Thomas M; Ujupan S; Vainer GW; Velthaus JL; André F
    J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of cancer next-generation sequencing testing in a community hospital.
    Akkari Y; Smith T; Westfall J; Lupo S
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls.
    Horak P; Fröhling S; Glimm H
    ESMO Open; 2016; 1(5):e000094. PubMed ID: 27933214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
    Cronin M; Ross JS
    Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics.
    Gullapalli RR; Desai KV; Santana-Santos L; Kant JA; Becich MJ
    J Pathol Inform; 2012; 3():40. PubMed ID: 23248761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of next-generation sequencing in personalized medicine.
    Popova L; Carabetta VJ
    ArXiv; 2024 Mar; ():. PubMed ID: 38495572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-Generation Sequencing and Result Interpretation in Clinical Oncology: Challenges of Personalized Cancer Therapy.
    Khotskaya YB; Mills GB; Mills Shaw KR
    Annu Rev Med; 2017 Jan; 68():113-125. PubMed ID: 27813876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, Prioritization, and Treatment of Mutations Identified by Next-Generation Sequencing.
    Mansfield AS; Park BH; Mullane MP
    Am Soc Clin Oncol Educ Book; 2018 May; 38():873-880. PubMed ID: 30231389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scenario drafting for early technology assessment of next generation sequencing in clinical oncology.
    Joosten SEP; Retèl VP; Coupé VMH; van den Heuvel MM; van Harten WH
    BMC Cancer; 2016 Feb; 16():66. PubMed ID: 26851938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
    Tazawa Y
    Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis.
    Sabour L; Sabour M; Ghorbian S
    Pathol Oncol Res; 2017 Apr; 23(2):225-234. PubMed ID: 27722982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genome sequencing and personalized medicine: perspectives and limitations].
    Le Gall JY; Debré P;
    Bull Acad Natl Med; 2014 Jan; 198(1):101-17. PubMed ID: 26259290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.